Cell loss in the nucleus basalis is related to regional cortical atrophy in Alzheimer's disease

Neuroscience

Volumn 78, Issue 3, 1997, Pages 641-652

  Cullen, K M ^a   Halliday, G M ^a,b   Double, K L ^b   Brooks, W S ^c   Creasey, H ^c   Broe, G A ^c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^c Department of Microbiology and Infectious Diseases   (Australia)

Author keywords

Alzheimer's disease; cortical atrophy; neurofibrillary tangles; nucleus basalis

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX ATROPHY; CHOLINERGIC NERVE CELL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; MAGNOCELLULAR NUCLEUS; MALE; NEUROFIBRILLARY TANGLE; NISSL STAINING; PRIORITY JOURNAL;

EID: 0030887764     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(96)00569-6     Document Type: Article

References (51)

1. Alzheimer A. (1911) Über eigenartige Krankheitsfaelle des spaeteren Alterns. Z. Neurol. Psychiat. 4, 356-385.
2. Arendt T., Bigl V., Arendt A. and Tennstedt A. (1983) Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's disease. Acta neuropath. 61, 101-108.
3. Arendt T., Bigl V., Tennstedt A. and Arendt A. (1985) Neuronal loss in different parts of the nucleus basalis is related to neuritic plaque formation in cortical target areas in Alzheimer's disease. Neuroscience 14, 1-14.
4. Beach T. G. and McGeer E. G. (1992) Senile plaques, amyloid β-protein, and acetylcholinesterase fibres: laminar distributions in Alzheimer's disease striate cortex. Acta neuropath. 83, 292-299.
5. Braak H. and Braak E. (1991) Neuropathological staging of Alzheimer-related changes. Acta neuropath. 82, 239-259.
6. Broe G. A., Henderson A. S., Creasey H., McCusker E., Korton A. E., Jorm A. F., Longley W. and Anthony J. C. (1990) A case control study of Alzheimer's disease in Australia. Neurology 40, 1698-1707.
7. Buée L., Hof P. R., Bouras C., Delacourte A., Perl D. P., Morrison J. H. and Fillit H. M. (1994) Pathological correlates of the cerebral microvasculature in Alzheimer's disease and related dementing disorders. Acta neuropath. 87, 469-480.
8. Celio M. and Norman A. W. (1985) Nucleus basalis of Meynert neurons contain vitamin D induced calcium binding protein. Anat. Embryol. 173, 143-148.
9. Cullen K. M., Halliday G. M., Cartwright H. and Kril J. J. (1996) Improved specificity in the visualization of neurofibrillary tangles, senile plaques and neuropil threads. Neurodegeneration 5, 177-186.
10. Davis K. L., Thal L. J., Gamzu E. R., Davis C. S., Woolson R. F., Gracon S. I., Frachman D. A., Schneider L., Whitehouse P. J., Hoover T. M., Morris J. C., Kawas C. H., Knopman D. S., Earl N. L., Kumar V., Doody R. S. and Group T. C. S. (1992) Tacrine in Alzheimer's disease: a double blind placebo controlled, multicentre study. New Engl. J. Med. 327, 1253-1259.
11. Davis P., Gearing M., Gray L., Mirra S., Morris J., Edland S., Lin T. and Heyman A. (1995) The CERAD experience, Part VIII: neuroimaging-neuropathology correlates of temporal lobe changes in Alzheimer's disease. Neurology 45, 178-179.
12. Double K. L., Halliday G. M., Kril J. J., Harasty J. A., Cullen K. M., Brooks W. S., Creasey H. and Broe G. A. (1996) Topography of brain atrophy during normal aging and Alzheimer's disease. Neurobiol. Aging 17, 513-521.
13. Farlow M., Gracon S. E., Hershey L. A., Lewis K. W., Sadowsky C. H. and Dolan-Ureno J. A. (1992) A controlled clinical trial of tacrine in Alzheimer's disease. J. Am. med. Ass. 268, 2523-2529.
14. Garvey W., Fathi A., Bigelow F., Jimenez C. L. and Carpenter B. F. (1991) Rapid, reliable and economical silver stain for neurofibrillary tangles and senile plaques. J. Histotech. 14, 39-42.
15. Geula C. and Mesulam M.-M. (1996) Systematic regional variations in the loss of cholinergic fibers in Alzheimer's disease. Cerebral Cortex 6, 165-177.
16. Golomb J., de Leon M. J., Kluger S., George A. E., Tarshish C. and Ferris S. H. (1993) Hippocampal atrophy in normal human aging. An association with recent memory impairment. Arch. Neurol. 50, 967-973.
17. Gundersen H. J. G., Bendtsen T. F., Korbo L., Marcussen N., Moller A., Nielsen K., Nyengaard J. R., Pakkenberg B., Sorensen F. B., Vesterby A. and West M. J. (1988) Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. Acta pathol. microbiol. immunol. Scand. 96, 379-394.
18. Halliday G. M., Flowers D. and Baum L. (1994) Analysis of staining methods for different cortical plaques in Alzheimer's disease. Acta neuropath. 87, 174-186.
19. Halliday G. M., Cullen K. M. and Cairns M. J. (1993) Quantitation and three-dimensional reconstruction of Ch4 nucleus in the human basal forebrain. Synapse 15, 1-16.
20. Halliday G. M., McCann H. L., Pamphlett R., Brooks W. S., Creasy H., McCusker E., Cotton R. G. H., Broe G. A. and Harper C. G. (1992) Brainstem serotonin-synthesizing neurons in Alzheimer's disease: a clinicopathological correlation. Acta neuropath. 84, 638-650.
21. Harasty J. A., Halliday G. M. and Kril J. J. (1996) Reproducible sampling regime for specific cortical regions: application to speech-associated areas. J. Neurosci. Meth. 67, 43-51.
22. Hefti F., Hartikka J., Salvatierra A., Weiner W. and Mash D. (1986) Localization of nerve growth factor receptors in cholinergic neurons of the human basal forebrain. Neurosci. Lett. 69, 37-41.
23. Heyman A., Wilkinson W. E., Hurwitz B. J., Helms M. J., Haynes B. A., Utley C. M. and Gwyther L. P. (1987) Early onset Alzheimer's disease: clinical predictors of institutionalization and death. Neurology 37, 980-984.
24. Iraizoz I., de Lacalle S. and Gonzalo L. M. (1991) Cell loss and nuclear hypertrophy in topographical subdivisions of the nucleus basalis of Meynert in Alzheimer's disease. Neuroscience 41, 33-40.
25. Jack C. R., Peterson R. C., O'Brien P. C. and Tangalos E. G. (1992) MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology 42, 183-188.
26. Kalaria R. N. and Hedera P. (1995) Differential degeneration of the cerebral microvasculature in Alzheimer's disease. NeuroReport 6, 477-480.
27. Kitt C. A., Mitchell S. J., DeLong M. R., Wainer B. H. and Price D. L. (1987) Fiber pathways of basal forebrain cholinergic neurons in monkeys. Brain Res. 406, 192-206.
28. Kobayashi K., Miyazu K., Fukutani Y., Nakamura I. and Yamaguchi N. (1991) Morphometric study on the CH4 of the nucleus basalis of Meynert in Alzheimer's disease. Molec. Chem. Neuropath. 15, 193-206.
29. Kobayashi K., Miyazu K., Nakamura I., Fukutani Y., Yamaguchi N. and Nakanishi I. (1992) Are there sequential morphometrical changes in the nucleus basalis in Alzheimer's disease?. Eur. Neurol. 32, 58-64.
30. Lehéricy S., Hirsch E. C., Cervera P. P., Hersh L. B., Bakchine S., Piette F., Duyckaerts C., Hauw J. J., Javoy A. F. and Agid Y. (1993) Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease. J. comp. Neurol. 330, 15-31.
31. Linville D. G., Williams S. and Arneric S. P. (1993) Basal forebrain control of cortical cerebral blood flow is independent of local cortical neurons. Brain Res. 622, 26-34.
32. Masliah E., Terry R. and Buzsáki G. (1989) Thalamic nuclei in Alzheimer disease: evidence against the cholinergic hypothesis of plaque formation. Brain Res. 493, 240-246.
33. Mesulam M.-M. (1990) Human brain cholinergic pathways. In Progress in Brain Research (eds Aquilonius S. M. and Gillberg P.-G.), Vol. 84, pp. 231-241. Elsevier, New York.
34. Mesulam M.-M. and Geula C. (1988) Nucleus basalis (Ch4) and cortical cholinergic innervation in the human brain: observations based on the distribution of acetylcholinesterase and choline acetyl transferase. J. comp. Neurol. 275, 216-240.
35. Mesulam M.-M., Mufson E. J., Levey L. and Wainer B. (1983) Cholinergic innervation of the cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata) and hypothalamus in rhesus monkey. J. comp. Neurol. 214, 170-197.
36. Minthon L., Nilsson K., Edvinsson L., Wendt P. and Gustafson L. (1995) Long-term effects of tacrine on regional cerebral blood flow changes in Alzheimers disease. Dementia 6, 245-251.
37. Mirra S., Heyman A., McKeel D., Sumi S., Crain B., Brownlee L., Vogel F., Hughes J., van Belle G. and Berg L. (1991) The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathological assessment of Alzheimer's disease. Neurology 41, 479-486.
38. Morris J., McKeel D. Jr, Storandt M., Rubin E., Price J., Grant E., Ball M. and Berg L. (1991) Very mild Alzheimer's disease: informant-based clinical, psychometric, and pathologic distinction from normal aging. Neurology 41, 469-478.
39. O'Brien J. T., Eagger S., Syed G. M., Sahakian B. J. and Levy R. (1992) A study of regional cerebral blood flow and cognitive performance in Alzheimer's disease. J. Neurol. Neurosurg. Psychiat. 55, 1182-1187.
40. Oorscht D. E. (1994) Are you using neuronal densities, synaptic densities, or neurochemical densities as your definitive data? There is a better way to go. Prog. Neurobiol. 44, 233-237.
41. Prochiantz A. and Mallat M. (1988) Astrocyte diversity. In Advances in Neuroimmunology (ed. Raine C. S.), Vol. 540, pp. 52-59. New York Academy of Science, New York.
42. Ransmayer G., Cervera P., Hirsch E. C., Berger W., Fischer W. and Agid Y. (1992) Alzheimer's disease: is the decrease of the cholinergic innervation of the hippocampus related to intrinsic hippocampal pathology. Neuroscience 47, 843-851.
43. Regeur L., Jensen B., Pakkenberg H., Evans S. M. and Pakkenberg B. (1994) No global neocortical nerve cell loss in brains from patients with senile dementia of the Alzheimer type. Neurobiol. Aging 15, 347-352.
44. Sasaki M., Ehara S., Tamakawa Y., Takahashi S., Tohgi H., Sakai A. and Mita T. (1995) MR anatomy of the substantia innominata and findings in Alzheimer disease - a preliminary report. Am. J. Neuroradiol. 16, 2001-2007.
45. Soinenen H., Partanen K., Helkala E.-L., Hartikainen P., Vaino P., Hänninen T. and Riekkinen Sr P. J. (1995) Volumes of hippocampus, amygdala, and frontal lobes in the MRI-based diagnosis of early Alzheimer's disease: correlation with memory functions. J. neural Transm. 9, 73-86.
46. Sokal R. and Rohlf F. (1995) Biometry. Freeman and Company, New York.
47. Vaucher E. and Hamel E. (1995) Cholinergic basal forebrain neurons project to cortical microvessels in the rat: electron microscopic study with anterogradely transported Phaseolus vulgaris leucoagglutinin and choline acetyl transferase immunohistochemistry. J. Neurosci. 15, 7427-7441.
48. Vogels O. J. M., Broere C. A. J., Lak H. J. T., Donkelaar H. J. T., Nieuwenhuys R. and Schultz P. M. (1990) Cell loss and shrinkage in the nucleus basalis of Meynert complex in Alzheimer's disease. Neurobiol. Aging 11, 3-13.
49. Weinstock M. (1995) The pharmacotherapy of Alzheimer's disease based on the cholinergic hypothesis: an update. Neurodegeneration 4, 349-356.
50. Whitehouse P., Price D., Clark A., Coyle J. and Delong M. (1981) Alzheimer's disease: evidence for a selective loss of cholinergic neurones in the nucleus basalis. Ann. Neurol. 10, 122-126.
51. Wolfe N., Reed B. R., Eberling J. L. and Jagust W. J. (1995) Temporal lobe perfusion on single photon emission computed tomography predicts the rate of cognitive decline in Alzheimer's disease. Arch. Neurol. 52, 257-262.